��ɫ��

��ɫ��

Events

Resources For

Abstract Details

Title Long-Term Safety and Efficacy of Safinamide Added to Dopamine Agonists in Early Parkinson[apos]s Disease (PD)

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Anthony Schapira (Royal Free Hospital Med Sch)	No disclosure on file
Rupam Borgohain, MD	No disclosure on file
	No disclosure on file
Fabrizio Stocchi	Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Pablo Lorenzana-Pombo, MD	No disclosure on file
Marco Onofrj, MD	Dr. Onofrj has nothing to disclose.
	No disclosure on file
	No disclosure on file
Stefano M. Rossetti, MD (Rossetti Consulting Sas)	No disclosure on file
Ravi Anand (Novartis Pharmacueticals)	No disclosure on file
	No disclosure on file